These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing. Houpt JB. J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661 [No Abstract] [Full Text] [Related]
11. Early hydroxychloroquine macular toxicity. Warner AE. Arthritis Rheum; 2001 Aug; 44(8):1959-61. PubMed ID: 11508449 [Abstract] [Full Text] [Related]
12. Hyperpigmentation of the skin due to hydroxychloroquine. Rood MJ, Vermeer MH, Huizinga TW. Scand J Rheumatol; 2008 Aug; 37(2):158. PubMed ID: 18415776 [No Abstract] [Full Text] [Related]
15. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine. Easterbrook M. J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662 [No Abstract] [Full Text] [Related]
18. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis. Unübol M, Ayhan M, Guney E. J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846 [No Abstract] [Full Text] [Related]